Steven R. Smith, MD, joins Zealand Pharma as Senior Global Medical Advisor in Obesity

Stock Information for Zealand Pharma A/S

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Zealand Pharma A/S

Zealand Pharma to participate in upcoming healthcare investor conferences in May and June 2025
Zealand Pharma announces closing of collaboration and license agreement with Roche
Zealand Pharma Announces Financial Results for the First Three Months of 2025
Zealand Pharma conference call on May 8 at 2pm CET (8am ET) to present first quarter 2025 financial results
Zealand Pharma announces first participant enrolled in Phase 2b ZUPREME-2 trial of petrelintide in people with overweight or obesity and type 2 diabetes
Zealand Pharma appoints Utpal Singh as Chief Scientific Officer to drive next-generation peptide therapeutics discovery
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Zealand Pharma launches long-term incentive programs for Zealand Pharma's Board of Directors, Corporate Management and employees for 2025

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.